<DOC>
	<DOCNO>NCT00313677</DOCNO>
	<brief_summary>The purpose study describe early sign symptom dystroglycanopathies , gather information require future clinical trial .</brief_summary>
	<brief_title>Clinical Trial Readiness Dystroglycanopathies</brief_title>
	<detailed_description>Muscular dystrophy diverse group inherit disorder characterize progressive muscle weakness wasting . The disorder cause mutation , change , gene . Genes tiny piece inherit material ( DNA ) direct body make certain kind protein . In study , researcher examine clinical presentation muscular dystrophy cause abnormal glycosylation alpha-dystroglycan . Patients dystroglycanopathies could mutations one 18 currently identify gene , evidence dystroglycanopathy biopsied muscle tissue . Symptoms range congenital muscular dystrophy may involve brain eye , adult-onset limb girdle muscular dystrophy . The study involve clinical evaluation University Iowa . The evaluation include muscle strength motor ability testing , lung function testing , quality life activity assessment , review past medical history . Portions evaluation repeat yearly basis . Financial assistance available travel Iowa City . Support also available genetic test people dystroglycanopathy diagnosis base muscle skin biopsy analysis . Knowledge gain study improve healthcare recommendation people dystroglycanopathies , provide baseline study , include potential treatment option .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<criteria>Elevated CK ( creatine kinase ) Evidence dystroglycanopathy determine review muscle pathology OR document mutation one know gene OR abnormal alphadystroglycan glycosylation culture fibroblast Dystroglycanopathies predict affect racial ethnic background , patient dystroglycanopathies eligible participation . Participants may age , include child , male female recruit equally . Patients vary degree muscular weakness , otherwise relatively good health . There exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>muscular dystrophy</keyword>
	<keyword>MD</keyword>
	<keyword>fukutin-related protein gene</keyword>
	<keyword>limb girdle</keyword>
	<keyword>FKRP gene</keyword>
	<keyword>congenital muscular dystrophy</keyword>
	<keyword>childhood onset LGMD</keyword>
	<keyword>adult onset LGMD</keyword>
	<keyword>POMT1</keyword>
	<keyword>POMT2</keyword>
	<keyword>POMGnT</keyword>
	<keyword>LARGE</keyword>
	<keyword>alpha dystroglycan</keyword>
	<keyword>dystroglycanopathy</keyword>
	<keyword>ISPD</keyword>
	<keyword>DPM</keyword>
	<keyword>GMPPB</keyword>
	<keyword>B3GNT1</keyword>
	<keyword>B3GALNT2</keyword>
	<keyword>GTDC2</keyword>
	<keyword>TMEM5</keyword>
	<keyword>Fukutin</keyword>
	<keyword>DAG1</keyword>
	<keyword>POMK</keyword>
</DOC>